Accession Number: | 0001333277-21-000022 |
Date: | 2021-01-26 |
Issuer: | CYMABAY THERAPEUTICS, INC. (CBAY) |
Original Submission Date: |
DICKINSON KLARA
C/O CYMABAY THERAPEUTICS, INC.
7575 GATEWAY BOULEVARD, SUITE 110
NEWARK, CA 94560
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 5.78 | 2021-01-26 | deemed execution date | A | 66,500 (a) | 2031-01-25 | common stock 66,500 | $5.78 | 66,500 | direct |
ID | footnote |
---|---|
f1 | the option vests as to 1/48 of the underlying shares monthly from january 1, 2021. |